reports
INOVIO Announces Notice of Pendency and Proposed Settlement of Stockho...
INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions Plymouth Meeting, Pa., June 23, 2023 (GLOBE NEWSWIRE) -- INOVIO (NASDAQ:INO) has released the following pursuant to an order of the UNITED STATES DISTRICT COURT EASTERN DISTRICT OF PENNSYLVANIA: UNITED STATES DISTRICT COURT EASTERN DISTRICT OF PENNSYLVANIA IN RE INOVIO PHARMACEUTICALS, INC. DERIVATIVE LITIGATION Lead Case No. 2:20-cv-01962-GJP NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDER DERIVATIVE ACTIONS TO: ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF...
INOVIO PHARMACEUTICALS sees a downgrade to Negative on account of less...
The independent financial analyst theScreener just lowered the general evaluation of INOVIO PHARMACEUTICALS (US), active in the Biotechnology industry. As regards its fundamental valuation, the title now shows 0 out of 4 stars while market behaviour can be considered risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Negative. As of the analysis date March 15, 2022, the closing price was USD 3.14 and its target ...
- Dave Nicoski
- Ross LaDuke
DHR DANAHER CORPORATION
VEEV VEEVA SYSTEMS INC CLASS A
USNA USANA HEALTH SCIENCES INC.
TSCO TRACTOR SUPPLY COMPANY
TBPH THERAVANCE BIOPHARMA INC
SMG SCOTTS MIRACLE-GRO COMPANY CLASS A
SLP SIMULATIONS PLUS
SLGN SILGAN HOLDINGS INC.
SFM SPROUTS FARMERS MARKETS INC.
RRC RANGE RESOURCES CORPORATION
RGEN REPLIGEN CORPORATION
RARE ULTRAGENYX PHARMACEUTICAL INC.
PYPL PAYPAL HOLDINGS INC
OLLI OLLIE'S BARGAIN OUTLET HOLDINGS INC
NLS NAUTILUS INC
NGVC NATURAL GROCERS BY VITAMIN COTTAGE INC
MTRN MATERION CORPORATION
MSCI MSCI INC. CLASS A
MOH MOLINA HEALTHCARE INC.
MMSI MERIT MEDICAL SYSTEMS INC.
MKTX MARKETAXESS HOLDINGS INC.
LMNX LUMINEX CORP
LDOS LEIDOS HOLDINGS INC.
INO INOVIO PHARMACEUTICALS INC.
HALO HALOZYME THERAPEUTICS INC.
HAE HAEMONETICS CORPORATION
GFI GOLD FIELDS LTD. ADS
GBT GLOBAL BLOOD THERAPEUTICS INC
FOLD AMICUS THERAPEUTICS INC.
EBS EMERGENT BIOSOLUTIONS INC.
CONE CYRUSONE INC.
CNC CENTENE CORPORATION
CIEN CIENA CORPORATION
CERS CERUS CORP.
CALX CALIX NETWORKS
BMRN BIOMARIN PHARMACEUTICAL INC.
AU ANGLOGOLD ASHANTI LTD. ADS
ASC ARDMORE SHIPPING
ALXN ALEXION PHARMACEUTICALS INC.
ALNY ALNYLAM PHARMACEUTICALS INC
ALLT ALLOT LTD
AGI. ALAMOS GOLD INC.
AAWW ATLAS AIR WORLDWIDE HOLDINGS INC.
MRVL MARVELL TECHNOLOGY GROUP LTD.
IRBT IROBOT CORPORATION
CCO. CAMECO CORPORATION
AEM. AGNICO EAGLE MINES LIMITED
NAT NORDIC AMERICAN TANKERS LIMITED
ENTG ENTEGRIS INC.
KLAC KLA CORPORATION
WERN WERNER ENTERPRISES INC.
MTSI MACOM TECHNOLOGY SOLUTIONS HOLDINGS INC.
WMK WEIS MARKETS INC.
FIZZ NATIONAL BEVERAGE CORP.
INSG INSEEGO CORP
PHI PHILIPPINE LONG DISTANCE TELEPHONE COMPANY ADS
OKTA OKTA INC. CLASS A
ARNA ARENA PHARMACEUTICALS INC.
QTRX QUANTERIX CORPORATION
SE SEA ADS
AMD ADVANCED MICRO DEVICES INC.
SWCH SWITCH
VICR VICOR CORP.
ALLO ALLOGENE THERAPEUTICS
TBIO TRANSLATE BIO
MR MONTAGE RESOURCES CORP.
BYND BEYOND MEAT
CRWD CROWDSTRIKE HOLDINGS INC. CLASS A
CLVT CLARIVATE PLC (A)
ATEX ANTERIX INC
ARCT ARCTURUS THERAPEUTICS HOLDINGS INC
SQNS SEQUANS COMMUNICATIONS ADR
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
The Only Thing We Have To Fear Is Fear Itself This powerful quote from FDR can be applied to many facets of life. When it comes to the market, fear can lead investors to buy when it is time to sell, sell when it is time to buy, or freeze up altogether. Step one in conquering this issue starts with preparation and a gameplan. In our report from last Thursday (3/12) titled “Searching For A Bottom†we laid out our gameplan and what we need to see before having confidence that equity markets ar...
AMGN AMGEN INC.
TSFA TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD. SPONSORED ADR
DPZ DOMINO'S PIZZA INC.
LITE LUMENTUM HOLDINGS INC.
ITW ILLINOIS TOOL WORKS INC.
AMN AMN HEALTHCARE SERVICES INC.
NOW SERVICENOW INC.
MASI MASIMO CORPORATION
AAON AAON INC.
XLRN ACCELERON PHARMA INC
WST WEST PHARMACEUTICAL SERVICES INC.
WEC WEC ENERGY GROUP INC
VRTX VERTEX PHARMACEUTICALS INCORPORATED
VNET 21VIANET GROUP INC. SPONSORED ADR CLASS A
VIPS VIPSHOP HOLDINGS LTD SPONSORED ADR
TSLA TESLA INC
TMO THERMO FISHER SCIENTIFIC INC.
TDOC TELADOC HEALTH INC.
STMP STAMPS.COM INC.
SGEN SEAGEN INC.
SEDG SOLAREDGE TECHNOLOGIES INC.
RMD RESMED INC.
RGEN REPLIGEN CORPORATION
REGN REGENERON PHARMACEUTICALS INC.
QDEL QUIDEL CORPORATION
POWI POWER INTEGRATIONS INC.
PG PROCTER & GAMBLE COMPANY
NOVA NOVO NORDISK A/S ADS
NVDA NVIDIA CORPORATION
NEH NETEASE INC. SPONSORED ADR
MUSA MURPHY USA INC.
MNST MONSTER BEVERAGE CORPORATION
3KA STRIDE INC.
LMNX LUMINEX CORP
LLY ELI LILLY AND COMPANY
KR KROGER CO.
KMB KIMBERLY-CLARK CORPORATION
K KELLOGG COMPANY
JNJ JOHNSON & JOHNSON
JD JD.COM INC. SPONSORED ADR CLASS A
INO INOVIO PHARMACEUTICALS INC.
HRL HORMEL FOODS CORPORATION
HAIN HAIN CELESTIAL GROUP INC.
GIS GENERAL MILLS INC.
FLO FLOWERS FOODS INC.
EPZM EPIZYME INC.
N1U NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC. SPONSORED ADR
EBS EMERGENT BIOSOLUTIONS INC.
DVA DAVITA INC.
DQ DAQO NEW ENERGY CORP SPONSORED ADR
CLX CLOROX COMPANY
CASY CASEY'S GENERAL STORES INC.
CALM CAL-MAINE FOODS INC.
BIIB BIOGEN INC.
A117ME ALIBABA GROUP HOLDING LTD. SPONSORED ADR
ALLT ALLOT LTD
AKAM AKAMAI TECHNOLOGIES INC.
ABC AMERISOURCEBERGEN CORPORATION
SCI SERVICE CORPORATION INTERNATIONAL
APS. APTOSE BIOSCIENCES
BIO BIO-RAD LABORATORIES INC. CLASS A
CCI CROWN CASTLE INTERNATIONAL CORP
ENPH ENPHASE ENERGY INC.
ZNGA ZYNGA INC. CLASS A
TR TOOTSIE ROLL INDUSTRIES INC.
EVBG EVERBRIDGE INC.
WDFC WD-40 COMPANY
ZTO ZTO EXPRESS (CAYMAN) INC. SPONSORED ADR CLASS A
WMT WALMART INC.
ASML ASML HOLDING N.V.
CODX CO-DIAGNOSTICS
KALA KALA PHARMACEUTICALS INC.
BKI BLACK KNIGHT INC.
ZLAB ZAI LAB LTD. SPONSORED ADR
SE SEA ADS
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
CTXS CITRIX SYSTEMS INC.
RHHBY ROCHE HOLDING AG ADS
RCUS ARCUS BIOSCIENCES
BILI BILIBILI INC. SPONSORED ADR CLASS Z
DOCU DOCUSIGN INC.
ZM ZOOM VIDEO COMMUNICATIONS INC. CLASS A
RAD RITE AID CORPORATION
VAPO VAPOTHERM
CLVT CLARIVATE PLC (A)
BJ BJ'S WHOLESALE CLUB HOLDINGS
VIR VIR BIOTECHNOLOGY
GSX GSX TECHEDU INC. SPONSORED ADR CLASS A
- Jonathan Moreland
WWW WOLVERINE WORLD WIDE INC.
TLYS TILLYS
STLD STEEL DYNAMICS INC.
SPKE SPARK ENERGY INC-CLASS A
NTAP NETAPP INC.
4LT1 NORTHERN OIL & GAS INC.
LTS LADENBURG THALMANN FINANCIAL SERVICES INC.
INO INOVIO PHARMACEUTICALS INC.
FRGI FIESTA RESTAURANT GROUP INC.
DVAX DYNAVAX TECHNOLOGIES CORPORATION
AKRX AKORN INC.
AEL AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
AAL AMERICAN AIRLINES GROUP INC.
HPR HIGH PEAK ROYALTIES
COLL COLLECTOR AB
CONN CONN'S INC.
WMK WEIS MARKETS INC.
EHI WESTERN ASSET GLOBAL HIGH INCOME FUND
TRC TEJON RANCH CO.
TPL TEXAS PACIFIC LAND CORPORATION
HIO WESTERN ASSET HIGH INCOME OPPORTUNITY FUND
NHF NEXPOINT CREDIT STRATEGIES FUN
NCSM NCS MULTISTAGE HOLDING
ICTSF I C T S INTL NV
OPNT OPIANT PHARMACEUTICALS
RBB RBB BANCORP
STXB SPIRIT OF TEXAS BANCSHARES
PRTS U.S. AUTO PARTS NETWORK
INMB INC.
CNR INMUNE BIO
CPRI INC.
SFLY CORNERSTONE BUILDING BRANDS INC
CAPRI NUSA SATU PROPERTI
SHUTTERFLY
INC.
- Jonathan Moreland
SKT TANGER FACTORY OUTLET CENTERS INC.
PXLW PIXELWORKS INC.
NVTRQ NUVECTRA
NRIM NORTHRIM BANCORP INC.
LUNA LUNA INNOVATIONS
LCI LANNETT COMPANY INC.
IVAC INTEVAC INC.
IRMD IRADIMED CORP
INO INOVIO PHARMACEUTICALS INC.
IEC IEC ELECTRONICS
HRZN HORIZON TECHNOLOGY FINANCE CORP.
HOO HERBALIFE NUTRITION LTD.
GTT GTT COMMUNICATIONS INC.
CMRX CHIMERIX INC
BOCH BANK OF COMMERCE HOLDINGS
AMRS AMYRIS
ADMA ADMA BIOLOGICS INC
MLVF MALVERN BANCORP
MBCN MIDDLEFIELD BANC CORP
EGY VAALCO ENERGY INC.
PCYG PARK CITY GROUP
SBPH SPRING BANK PHARMACEUTICALS
MTNB MATINAS BIOPHARMA HOLDINGS INC
ORN ORION MINERALS LIMITED
CERC CERECOR INC
HIL HILL INTERNATIONAL
RAIL FREIGHTCAR AMERICA INC.
SITE SITEONE LANDSCAPE SUPPLY INC.
AP AMPCO-PITTSBURGH
KINS KINGSTONE COS. INC.
LCUT LIFETIME BRANDS
NOVN NOVAN INC
NVUS NOVUS THERAPEUTICS INC.
RIBT RICEBRAN TECHNOLOGIES
BBGI BEASLEY BROADCAST GROUP INC. CL A
ESQ ESQUIRE FINANCIAL HOLDINGS
SFIX STITCH FIX CLASS A
RMBL RUMBLEON INC
RDVT RED VIOLET
NICK NICHOLAS FINANCIAL INC.
WLMS WILLIAMS INDUSTRIAL SERVICES GROUP INC.
PRTS U.S. AUTO PARTS NETWORK
SLGG INC.
INMB SUPER LEAGUE GAMING
BSGM INMUNE BIO
EDNT INC.
APRN BIOSIG TECHNOLOGIES INC.
BW EDISON NATION
DRAD BLUE APRON HOLDINGS
WW BABCOCK & WILCOX ENTERPRISES
EVLV DIGIRAD
IDSY WEIGHT WATCHERS INTERNATIONAL
DFRG INC.
EVINE LIVE INC.
I.D. SYSTEMS
INC.
DEL FRISCO'S RESTAURANT GROUP
LLC
- Jonathan Moreland
WETF WISDOMTREE INVESTMENTS INC.
VIVO MERIDIAN BIOSCIENCE INC.
SGA SAGA COMMUNICATIONS INC. CL A
SATS ECHOSTAR CORPORATION CLASS A
PFLT PENNANTPARK FLOATING RATE CAPITAL LTD.
OPK OPKO HEALTH INC.
NLY ANNALY CAPITAL MANAGEMENT INC.
M MACY'S INC
LTS LADENBURG THALMANN FINANCIAL SERVICES INC.
IRMD IRADIMED CORP
INO INOVIO PHARMACEUTICALS INC.
EPC EDGEWELL PERSONAL CARE CO.
OVINTIV INC
DISH DISH NETWORK CORPORATION CLASS A
LUMN LUMEN TECHNOLOGIES INC.
CLR CONTINENTAL RESOURCES INC.
BG BUNGE LIMITED
ARR ARMOUR RESIDENTIAL REIT INC.
APLE APPLE HOSPITALITY REIT INC
ADMA ADMA BIOLOGICS INC
MLVF MALVERN BANCORP
FRBK REPUBLIC FIRST BANCORP INC.
BW BABCOCK & WILCOX ENTERPRISES
ADC AGREE REALTY CORPORATION
CERC CERECOR INC
ELY CALLAWAY GOLF COMPANY
HIL HILL INTERNATIONAL
MAC MACERICH COMPANY
SITE SITEONE LANDSCAPE SUPPLY INC.
AP AMPCO-PITTSBURGH
EHI WESTERN ASSET GLOBAL HIGH INCOME FUND
CC CHEMOURS CO.
OTEL OTELCO INC
TPB TURNING POINT BRANDS
UIHC UNITED INSURANCE HOLDINGS CORP.
ASIX ADVANSIX INC.
HAIN THE HAIN CELESTIAL GROUP
NOVN INC.
SNAP NOVAN INC
CNDT SNAP INC. CLASS A
MDCO CONDUENT INC.
CLF THE MEDICINES COMPANY
STKL CLIFFS NATURAL RESOURCES INC.
SFIX SUNOPTA
TDW INC.
WTBA STITCH FIX CLASS A
FUND TIDEWATER INC
WLMS WEST BANCORP INC.
PRTS ROYCE FOCUS TRUST
WAB INC.
CHAP WILLIAMS INDUSTRIAL SERVICES GROUP INC.
SLGG U.S. AUTO PARTS NETWORK
INMB INC.
BSGM WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
CHAPARRAL ENERGY
INC.
SUPER LEAGUE GAMING
INMUNE BIO
INC.
BIOSIG TECHNOLOGIES INC.
- Jonathan Moreland
VIVO MERIDIAN BIOSCIENCE INC.
SGA SAGA COMMUNICATIONS INC. CL A
OPK OPKO HEALTH INC.
NVTRQ NUVECTRA
LTS LADENBURG THALMANN FINANCIAL SERVICES INC.
INO INOVIO PHARMACEUTICALS INC.
EPC EDGEWELL PERSONAL CARE CO.
OVINTIV INC
LUMN LUMEN TECHNOLOGIES INC.
BG BUNGE LIMITED
ARR ARMOUR RESIDENTIAL REIT INC.
AR ANTERO RESOURCES CORPORATION
ADMA ADMA BIOLOGICS INC
AAWW ATLAS AIR WORLDWIDE HOLDINGS INC.
MLVF MALVERN BANCORP
FRBK REPUBLIC FIRST BANCORP INC.
ELY CALLAWAY GOLF COMPANY
MAC MACERICH COMPANY
TSC TRISTATE CAPITAL HOLDINGS INC
SITE SITEONE LANDSCAPE SUPPLY INC.
AP AMPCO-PITTSBURGH
EHI WESTERN ASSET GLOBAL HIGH INCOME FUND
TPL TEXAS PACIFIC LAND CORPORATION
TPB TURNING POINT BRANDS
AMBC AMBAC FINANCIAL GROUP INC.
NOVN NOVAN INC
CNDT CONDUENT INC.
CLF CLIFFS NATURAL RESOURCES INC.
TDW TIDEWATER INC
WTBA WEST BANCORP INC.
FUND ROYCE FOCUS TRUST
INC.
Inovio Announces Initiation of “MD Anderson’s HPV-Related Cancers ...
Inovio Announces Initiation of “MD Anderson’s HPV-Related Cancers Moon Shot” Phase 2 Trial in New HPV Indications Phase 2 cancer study will evaluate T cell-activating immunotherapy MEDI0457 with MedImmune’s durvalumab targeting several HPV-related cancers PLYMOUTH MEETING, Pa., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today the dosing of the first patient in a Phase 2 combination trial to evaluate MedImmune’s MEDI0457 (formerly called INO-3112 which MedImmune in-licensed from Inovio) in combination with durvalumab targeting a broad array of ca...
Inovio Further Demonstrates Potency of its DNA-Encoded Monoclonal Anti...
Inovio Further Demonstrates Potency of its DNA-Encoded Monoclonal Antibody (dMAb™) Platform in Three Preclinical Publications and Prepares for First Clinical Trial in Early 2019 PLYMOUTH MEETING, Pa., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that three recent published studies of its DNA-Encoded monoclonal antibody (dMAb™) technology showed impressive results in treating cardiovascular disease and in preventing infection from the Ebola virus and Lyme disease-causing bacteria in preclinical models. Leveraging several recent published posi...
Inovio Prepares for Growth & Commercialization With Leadership Appoin...
Inovio Prepares for Growth & Commercialization With Leadership Appointments Prominent immunologist joins Scientific Advisory BoardR&D leader appointed Chief Scientific OfficerIndustry veteran appointed Vice President, Commercial PLYMOUTH MEETING, Pa., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) made strategic leadership appointments in preparation for the commercialization of its lead asset and further development of its pipeline of immunotherapies and vaccines for cancer and challenging infectious diseases. Inovio appointed to its Scientific Advisory Bo...
Inovio Pharmaceuticals Reports 2018 Third Quarter Financial Results
Inovio Pharmaceuticals Reports 2018 Third Quarter Financial Results PLYMOUTH MEETING, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO), a late-stage biotechnology company focused on the development and commercialization of DNA immunotherapies targeted against cancers and infectious diseases, today reported financial results for the third quarter ended September 30, 2018. Inovio’s management will host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss financial results and provide a general business update. Inovio Highlights ...
Inovio Pharmaceuticals to Participate in Upcoming Investment Conferenc...
Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences PLYMOUTH MEETING, Pa., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that the Company will participate in the following upcoming investment conferences: Stifel 2018 Healthcare ConferencePresentationDr. J. Joseph Kim, President & CEONovember 14, 2018, 11:45 AM ETNew York, NY Piper Jaffray 30th Annual Healthcare ConferenceFireside ChatDr. J. Joseph Kim, President & CEONovember 27, 2018, 1:30 PM ETNew York, NY Citi Global Healthcare Conference1x1 meetings onlyDecember 5-...
Inovio HIV Vaccine PENNVAX®-GP Delivered Intradermally Generated Rob...
Inovio HIV Vaccine PENNVAX®-GP Delivered Intradermally Generated Robust, Long-Term Best-In-Class Antibody and T Cell Immune Responses PLYMOUTH MEETING, Pa., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that its synthetic HIV vaccine PENNVAX®-GP delivered via intradermal route demonstrated durable and robust antibody and T cell immune responses measured throughout the duration of the Phase 1 clinical study. In this reported study, PENNVAX-GP plasmids were delivered intradermally or intramuscularly with CELLECTRA® device in healthy volunteers. ...
Inovio Pharmaceuticals to Report Third Quarter 2018 Financial Results...
Inovio Pharmaceuticals to Report Third Quarter 2018 Financial Results on November 8, 2018 PLYMOUTH MEETING, Pa., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it will host a conference call and live webcast to report its 2018 third quarter financial results on Thursday, November 8, 2018 at 4:30 p.m. ET. A live and archived version of the audio presentation will be available online at . This is a listen-only event but will include a live Q&A with analysts. A replay of the conference call will be accessible two hours after the call at 87...
Inovio Presents Progression Free Survival & PSA Doubling Time Improve...
Inovio Presents Progression Free Survival & PSA Doubling Time Improvements in Prostate Cancer Patients Treated with INO-5150 Study Results Presented at a Major European Cancer Conference (ESMO) PLYMOUTH MEETING, Pa., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that new data from the company’s recently completed Phase 1b study with INO-5150 demonstrated a slowing of Prostate-Specific Antigen Doubling Time (PSADT) in men with prostate cancer. Eighty six percent (86%) of patients remained progression-free at Week 72 of the study. These data w...
Inovio’s Ebola Vaccine Provides 100% Protection And Elicits Long-Las...
Inovio’s Ebola Vaccine Provides 100% Protection And Elicits Long-Lasting Immune Responses in Preclinical Studies Article in Journal of Infectious Diseases Supports RationaleFor Inovio’s Ebola Vaccine Stockpile Program PLYMOUTH MEETING, Pa., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that its Ebola vaccine (INO-4212) provided 100% protection following a challenge with a lethal dose of the Ebola virus in a preclinical study. An article in the highlights that regimens of Inovio’s INO-4212 vaccine delivered by intramuscular administration pro...
Inovio Successfully Develops First DNA-Encoded Monoclonal Antibody (d...
Inovio Successfully Develops First DNA-Encoded Monoclonal Antibody (dMAb™) Checkpoint Inhibitor and Demonstrates Tumor Shrinkage in Preclinical Studies Advancement highlighted in prestigious AACR journal Cancer Research PLYMOUTH MEETING, Pa., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today the successful animal testing of DNA-encoded monoclonal antibodies targeting the immune checkpoint molecule CTLA-4 as published in Cancer Research. The breakthrough preclinical study demonstrated that highly optimized dMAbs targeting mouse CTLA-4 protein c...
Major Cancer Journal Highlights Data From An Inovio-Sponsored Trial In...
Major Cancer Journal Highlights Data From An Inovio-Sponsored Trial In Which A Patient Achieved Full Remission After Dosing With DNA Immunotherapy and Checkpoint Inhibitor Study results published in Clinical Cancer Research shows that DNA immunotherapy approach drove T cell infiltration in tumors PLYMOUTH MEETING, Pa., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today a paper published in a major cancer journal detailed results of a patient with head and neck cancer treated with MEDI0457 achieved a sustained complete response (full remission) on...
Inovio Develops Novel H3N2 Influenza DNA Vaccine That Generates Cross-...
Inovio Develops Novel H3N2 Influenza DNA Vaccine That Generates Cross-Reactive Responses and Provides Complete Protection Against Lethal Preclinical Challenges H3N2 virus has been one of the most deadly flu strains in the past 50 years;And is always matched with the least effective seasonal influenza vaccine Preclinical work is supported by an NIH grant PLYMOUTH MEETING, Pa., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that its SynCon® vaccine approach using a collection of DNA antigens generated broadly protective antibody responses agai...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.